Although gastric cancer (GC) in young adults (≤ 45 years) accounts for fewer than 10% of newly diagnosed cases, the young patients are more likely to have advanced disease at presentation compared with elderly patients. Previous studies have identified that the DNA methylation of genomes are different during aging. Our study aimed to explore the association between DNA methylation and the onset of GC. We applied Illumina HumanMethylation450 BeadChip to examine methylation expression profiles and compared methylation expression patterns in five early onset GC patients and seven elderly patients. Additionally, we evaluated the associations of methylation expression with different clinicopathological characteristics of GC. Our results showed that the pattern of genome-wide methylation expression was significantly different between early onset and elderly GC. The top 10 hypomethylation and hypermethylation CpG sites were selected for further analyses in The Cancer Genome Atlas (TCGA) database. We found that the hypermethylation of cg11037477, located at the promoter of EIF4E, was significantly associated with age at diagnosis and the expression of EIF4E. Besides, GC patients with high level of cg11037477 were more likely to have advance disease with T3/T4 invasion and III/IV stage. The cg11037477 hypermethylation and EIF4E down-expression were significantly related to poor survival of GC patients. Our study provides new insights into the molecular mechanism of early onset patients with GC and suggests that methylation of cg11037477 and expression of EIF4E may act as prognostic markers in GC.
Introduction
Despite the incidence and mortality of gastric cancer (GC) are steadily decreasing since the middle of the 20th century, GC is still the third leading cause of cancer-related deaths, with about 951 600 new GC cases and 723 100 deaths estimated to have occurred in 2012 around the world (1) . Reportedly, GC is the third contributor to the disability-adjusted life-years (DALYs) burden from cancer in men and accounting for 20% for the total DALYs around the world (2, 3) . Currently, adequate surgical resection and chemotherapy regimens are the curative therapeutic for GC. However, the majority of GC patients present with advanced-stage disease, resulting in only 20% 5-year survival rates (4) . Furthermore, the outcomes of metastatic disease are even poorer, with 1 year of median survival (5) .
A previous study has indicated that the annual percentage change of the incidence of GC was decreased in the entire cohorts except young Hispanic men (6) . Although GC in young adults (≤ 45 years) is rare and accounts for fewer than 10% of newly diagnosed cases (7) (8) (9) , the incessant treatments have serious physical and psychosocial impact on their lives. The long-term survivors were at increased risk of adverse effect including growth, fertility and secondary cancers. Besides, the effects are noteworthy in those productive members of society, which had a negative effect on social development (10) (11) (12) . In addition, mounting studies reported that compared with elderly patients, the young patients with GC were more likely to have distant metastases, higher grade and adjacent organ invasion and poorer survival (8, 13, 14) . It has been reported that molecular genetic mechanisms of early onset cancers are distinct different from elderly ones (9, 15) . However, the characters and the molecular mechanisms between young and elderly GC patients remain largely unexplained. In addition to genetic susceptibility, environmental factors such as H.pylori infection, EBV infection, diet and smoking are able to increase the risk of GC (5). It is noteworthy that H.pylori and EBV infections are significantly associated with the induction of aberrant DNA methylation. To date, increasing studies have identified age-related methylation changes in various organisms and tissues (16) (17) (18) . There has been wide consensus that aberrant DNA methylation in gene promoters plays a key role in the carcinogenesis of GC (19) (20) (21) . Our study aimed to reveal the biological differences between early onset and elderly GC patients by methylation alterations and identified agerelated CpG sites and potential genes involved in early onset GC.
Materials and methods
This study was approved by the international review board of Nanjing Medical University. A total of five early onset (≤ 45 years) GC patients and seven elderly GC patients were recruited from the Second Affiliated Hospital of Nanjing Medical University. We carried out comparative genome-wide analysis of DNA methylation between early onset GC and elderly patients, using Illumina HumanMethylation450 BeadChip (450K), which is widely applied to quantify DNA methylation and contains more than 480 000 CpG sites across the whole genome. The probes include 99% of RefSeq genes, 96% of CpG island and CpG island shores (22, 23) . We also analyzed DNA methylation expression (n = 327) in gastric tissues from Illumina 450K BeadChip in The Cancer Genome Atlas (TCGA) database to validate findings in the discovery phase. The mRNA levels (n = 271) in gastric tissues were also available from Illumina Hiseq RNA Sequencing in TCGA. In addition, an online database, the Kaplan-Meier Plotter (http:// kmplot.com/analysis/), which integrates clinical data and gene expression simultaneously. The Kaplan-Meier Plotter is able to investigate the effect of 54 675 genes on the survival of cancer patients, including 1065 gastric, 4142 breast, 1648 ovarian and 2437 lung patients (24) . Gene expression profiling and clinical information of gastric cancer patients, GSE15459, was downloaded from Gene Expression Omnibus (GEO) database and applied to assess the prognostic value of genes (25) .
Statistical analysis
Comparisons of methylation levels between groups were carried out with Student's t test. The chi-square tests were performed to compare the distributions of cg11037477 methylation levels between clinicopathological characteristics, such as sex, distant metastasis and TNM stage. We evaluated the associations between cg11037477 methylation and age at initial pathologic diagnosis and EIF4E expression by Pearson correlation analysis and linear regression. The Kaplan-Meier analysis and log-rank test were applied to assess the effects of cg11037477 and EIF4E expression on clinical outcomes of GC from TCGA database. The Kaplan-Meier Plotter and GEO database were also used to assess the effect of EIF4E on survival of GC patients. All statistical analyses were two-sided and P < 0.05 was defined as statistically significant. Statistical analyses were performed with R software version 3.3.1.
Results

Discovery and selection of differentially expressed CpG sites
We detected the methylation levels in five early onset GC patients (≤ 45 years) and seven elderly GC patients. Illumina HumanMethylation450 BeadChip was applied to compare the global CpG site expression patterns and identified differentially expressed CpG sites. Totally, about 480 000 human CpG sites on the chip were expressed. We found that the methylation levels of multiple CpG sites were significantly different between early onset and elderly GC patients. The heat map diagram was generated using hierarchical unsupervised clustering and describes a prominent differential methylation expression in patients with early onset GC compared with elderly (Supplementary Figure 1A) . The −log 10 P value of each CpG site was plotted against log 2 fold change to generate a volcano plot to show the statistical significance and magnitude of fold change for each CpG site (Supplementary Figure 1B) . KEGG pathway analysis was used to investigate the potential functions of the differentially methylated genes. As shown in Supplementary Figure 2 , the pathway analysis revealed that genes containing aberrant CpG loci were most significantly involved in the PI3K-AKT signaling pathway. Based on the results of methylation array, the top 10 hypomethylation and hypermethylation CpG sites were selected for further analyses, and the details of these CpG sites are shown in Table 1 .
Validation of significant CpG sites in the TCGA database
The associations between age and methylation levels of the significant CpG sites were investigated in the TCGA database. The results showed that cg11037477, cg19461320 and cg00459845 were significantly correlated with age at initial pathologic diagnosis (r = −0.184, P = 1.9 × 10 -3 ; r = −0.120, P = 4.3 × 10 -2 ; r = 0.127, P = 3.3 × 10 -2 , respectively; Table 2 ; Figure 1A ). Furthermore, we evaluated the relationship between CpG methylation and its corresponding gene expression. Finally, only the methylation level of cg11037477 was negatively associated with the expression of EIF4E (r = −0.231, P = 4.6 × 10 -4 ; Figure 1B ).
Association between methylation and clinicopathological characteristics
We next assessed the relationships between the methylation level of cg11037477 and clinicopathological characteristics in 269 GC patients. The patient samples were divided into two groups according to the median of cg11037477 methylation levels. The clinicopathological characteristics of low and high expression groups are summarized in The Cancer Genome Atlas and high expression patients showed no significant difference in sex, lymph node metastasis and distant metastasis. However, a higher depth of invasion was remarkably distributed among high expression groups than patients with low expression of cg11037477 (P = 0.022). In addition, the high expression of cg11037477 was also significantly associated with the TNM stage (P = 0.024). In summary, GC patients with high β-score of cg11037477 are more likely to have advanced disease.
The impact of methylation and gene expression on GC survival Figure 2 shows the Kaplan-Meier for cg11037477 methylation and EIF4E expression and survival in GC patients from the TCGA database. A significantly poorer outcome was observed for patients with high methylation compared with patients with low methylation (log-rank P = 0.026; Figure 2A ). Furthermore, our results indicated that the low expression of EIF4E was significantly correlated with poor survival in patients with GC (logrank P = 0.031; Figure 2B ). In addition, Kaplan-Meier plotter, a free online tool, was applied to assess the prognostic value of EIF4E expression in GC. In line with the results from the TCGA database, the Kaplan-Meier Plotter database results showed a prominent poorer survival for patients with low expression of EIF4E than those with high levels of EIF4E (log-rank
; Figure 3 ). Besides, a similar result was obtained in the Gene Expression Omnibus (GEO) database (log-rank P = 0.010; Supplementary Figure 3) .
Discussion
The differences of molecular mechanisms implicated in early onset and elderly GC patients are largely unexplored. In the present study, through a combination of the Illumina HumanMethylation450 BeadChip and TCGA public database, we found that hypermethylation of cg11037477, located at the promoter of EIF4E, was significantly associated with age at diagnosis and the expression of EIF4E. Besides, the methylation of cg11037477 was also prominent related to the progression and prognosis of GC.
Although the incidence of early onset GC is relatively rare, compared with elderly GC patients, the early onset ones tend to present with advanced disease, which may contribute to poor survival. Therefore, it is important to develop effective markers to identify those early onset gastric cancer patients at earlier stages. Genome-wide association studies and next generation sequencing have identified multiple single nucleotide polymorphisms (SNPs) (26, 27) , somatic mutations (28) and indels (29) involved in the GC risk. Previous studies have indicated that GC of young and elderly patients belongs to a group with distinct genomic profiles, which may reflect different molecular mechanisms of the GC (9, 15) . One research has indicated that the most frequent losses of heterozygosity were detected near the RUNX3, TP53 and CDH1 in the early onset GC patients and manifested that early onset GC displays characteristics different from GC presenting at a later age (9) . Another study explored different patterns of DNA copy number alterations in association with the age of onset of GC and found that chromosome regions 19p13.3 and 11q23.3 may involve in age-related differences in tumor profiles (15) .
In addition to the DNA sequence alterations, it is well known that DNA methylation plays an important role in regulating gene expression and contributes to complex disease susceptibility (30, 31) . Numerous evidence showed that genetic variation, environmental and stochastic factors may regulate DNA methylation levels at individual genomic regions (32) (33) (34) (35) . It has been reported that DNA methyaltion patterns differ with age and compared with newborns, centenarians have more hypomethylated CpGs (16, 36) . Takane et al. revealed that an aberrant promoter methylation of EFHD1 and PPP1R3C was frequently positive in colorectal cancer, and it might be a useful marker in diagnose of early stage colorectal cancer (37) . To investigate differences of DNA methylation alterations in relation to the early onset GC, we applied a methylation chip to explored differences in global DNA methylation between early onset and elderly patients with GC. The results of methylation array showed that the patterns of genome-wide methylation were significantly different between early onset and elderly GC, indicating that early onset GC has characteristics distinct from elderly GC patients. Top 10 hypomethylated and hypermethylated CpG sites were validated in the further analyses using the TCGA database. TCGA results indicated that methylation of three CpG sites (cg11037477, cg19461320 and cg00459845) were remarkably related to age at diagnosis of patients with GC. In addition, we found that the methylation level of cg11037477 showed a significantly negative association with EIF4E expression by integrating the gene expression data with methylation data.
The eukaryotic translation initiation factor 4E (EIF4E) belonged to the PI3K-AKT pathway, which is involved in regulating various cellular functions including cell proliferation, growth, motility and angiogenesis. It is well established that the PI3K-AKT pathway plays a crucial role in the oncogenesis, and emerging evidence showed that deregulations of this pathway was implicated in GC. EIF4E acts as a member of the PI3K-AKT signaling pathway, and its activation and expression are correlated with tumorgenesis and progression of GC (38) (39) (40) (41) . It is noteworthy that our KEGG pathway analysis result shows that the differentially methylated genes were most significantly involved in the PI3K-AKT signaling pathway. A prominent negative association between the methylation level of age-related cg11037477 and EIF4E expression was observed in our study, which indicated that cg11037477 regulated the EIF4E expression. It has been reported that a more advanced disease is present in young patients with GC. The younger patients were more likely to have invasion, high grade and distant metastases (6, 8, 13) . We investigated the relationship between the methylation of cg11037477 and clinicopathological characteristics. The results demonstrated that GC patients with high levels of cg11037477 are more likely to have higher depths of invasion and higher TNM stages. Considering that cg11037477 was associated with an advanced disease, we assessed the prognostic effect of cg11037477 and EIF4E expression on the survival of GC patients. The log-rank and KaplanMeier plot indicated that hypermethylation of cg11037477 and low expression of EIF4E are associated with poor survival of patients with GC. On the basis of these results, we speculate that hypermethylation of cg11037477 may regulate the expression of EIF4E, which contributes to the deregulation of the PI3K-AKT pathway, thus involved in the progress and prognosis of gastric cancer.
In conclusion, our results revealed that the age-related CpG site,cg11037477, was associated with EIF4E expression. Meanwhile, GC patients with high levels of cg11037477 were more likely to have advance disease with T3/T4 invasion and III/IV stage. Furthermore, cg11037477 hypermethylation and EIF4E down-expression were significantly associated with poor survival of patients with GC. Our study provides new insights into the molecular mechanism of early onset patients with GC and suggests that methylation of cg11037477 and expression of EIF4E may act as prognostic markers in GC. Supplementary Figures 1-3 
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